Back to News
Market Impact: 0.15

FSTA vs. RSPS: Which Consumer Staples ETF Is the Better Buy Right Now?

COSTWMTPGIVZNFLXNVDANDAQ
Consumer Demand & RetailMarket Technicals & FlowsInvestor Sentiment & PositioningCapital Returns (Dividends / Buybacks)Company FundamentalsAnalyst Insights
FSTA vs. RSPS: Which Consumer Staples ETF Is the Better Buy Right Now?

The piece compares Fidelity’s MSCI Consumer Staples Index ETF (FSTA) and Invesco’s S&P 500 Equal Weight Consumer Staples ETF (RSPS), highlighting FSTA’s much lower expense ratio (0.08% vs. 0.40%) and larger AUM ($1.4B vs. $250M) versus RSPS’s stronger 1-year return (12.60% vs. 8.73%). Over five years FSTA shows a smaller max drawdown (-16.57% vs. -18.61%) and higher growth of $1,000 ($1,380 vs. $1,081); FSTA is market-cap weighted and concentrated in mega-caps (top three >33% including Costco, Walmart, P&G) while RSPS equally weights 36 S&P 500 staples (~3% each), yielding different risk/return and single-stock exposure profiles. Fees translate to roughly $8/year per $10,000 for FSTA versus $40 for RSPS, a consideration for long-term allocations.

Analysis

Market structure: The fee and scale advantage (FSTA $1.4B, 0.08% vs RSPS $250M, 0.40%) directs passive flows toward FSTA, concentrating buying into mega-cap staples (COST, WMT, PG >33% of FSTA) and improving their relative liquidity and valuation. Equal-weight RSPS benefits mid-cap staples via diversification and slightly higher yield (2.63% vs 2.18%), but faces outflow risk on fee sensitivity. Cross-asset: a sustained shift into defensive staples ETFs would modestly compress sovereign yields (flight-to-safety), reduce equity market beta, and raise demand for agricultural inputs indirectly through retailer inventories over months. Risk assessment: Tail risks include antitrust/regulatory action against large retailers, abrupt commodity-price spikes lifting input costs (20%+ food inflation shocks), or a sudden re-rating if CPI falls quickly and real rates rise >50bp. Immediate (days): ETF flow-driven intraday liquidity moves in COST/WMT options; short-term (weeks/months): quarterly rebalances and AUM shifts; long-term (years): structural concentration risk if a top-3 name underperforms. Hidden dependencies: index methodology drift, tax-loss selling in RSPS with low AUM, and dividend sustainability if margins compress. Trade implications: Core tactical: prefer low-cost core exposure via FSTA for buy-and-hold (fee drag ~32bp annual differential matters at >$500k). Relative alpha: implement a pair (long RSPS, short FSTA) sized 1–2% notional to capture potential mid-cap mean-reversion over 6–12 months if economic activity normalizes. Options: buy 3–6 month call spreads on COST and WMT (target 5–8% OTM) sized 0.25–0.5% notional each around earnings; sell 1-month covered calls on FSTA to monetize yield if implied vol < historical vol by >20%. Contrarian angles: Consensus understates single-stock concentration risk in FSTA — a 10% drawdown in COST or WMT would drag FSTA materially more than RSPS. Conversely, RSPS’s recent 1-year outperformance (12.6% vs 8.7%) signals underappreciated upside if mid-cap staples re-rate; consider that equal-weight outperformance episodes have persisted 6–18 months post-cyclic recovery historically. Unintended consequence: rapid herding into FSTA could create liquidity squeezes in top holdings’ options and exacerbate volatility on negative earnings surprises.